BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32127734)

  • 1. Role of cannabis in inflammatory bowel diseases.
    Perisetti A; Rimu AH; Khan SA; Bansal P; Goyal H
    Ann Gastroenterol; 2020; 33(2):134-144. PubMed ID: 32127734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manipulation of the Endocannabinoid System in Colitis: A Comprehensive Review.
    Leinwand KL; Gerich ME; Hoffenberg EJ; Collins CB
    Inflamm Bowel Dis; 2017 Feb; 23(2):192-199. PubMed ID: 28079617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis and the Gastrointestinal Tract.
    Cohen L; Neuman MG
    J Pharm Pharm Sci; 2020; 23():301-313. PubMed ID: 32762830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review.
    Hryhorowicz S; Kaczmarek-Ryś M; Zielińska A; Scott RJ; Słomski R; Pławski A
    Front Immunol; 2021; 12():790803. PubMed ID: 35003109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cannabis in digestive disorders.
    Goyal H; Singla U; Gupta U; May E
    Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):135-143. PubMed ID: 27792038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids and gastrointestinal motility: animal and human studies.
    Aviello G; Romano B; Izzo AA
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():81-93. PubMed ID: 18924447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoids and the gastrointestinal tract.
    Massa F; Monory K
    J Endocrinol Invest; 2006; 29(3 Suppl):47-57. PubMed ID: 16751708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis for inflammatory bowel disease.
    Naftali T; Mechulam R; Lev LB; Konikoff FM
    Dig Dis; 2014; 32(4):468-74. PubMed ID: 24969296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids and the gut: new developments and emerging concepts.
    Izzo AA; Sharkey KA
    Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Use of Cannabis in Inflammatory Bowel Disease.
    Ahmed W; Katz S
    Gastroenterol Hepatol (N Y); 2016 Nov; 12(11):668-679. PubMed ID: 28035196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease?
    Ambrose T; Simmons A
    J Crohns Colitis; 2019 Mar; 13(4):525-535. PubMed ID: 30418525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract.
    Massa F; Storr M; Lutz B
    J Mol Med (Berl); 2005 Dec; 83(12):944-54. PubMed ID: 16133420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis and Cannabis Derivatives for Abdominal Pain Management in Inflammatory Bowel Disease.
    Bogale K; Raup-Konsavage W; Dalessio S; Vrana K; Coates MD
    Med Cannabis Cannabinoids; 2021; 4(2):97-106. PubMed ID: 35224429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.
    Alhouayek M; Muccioli GG
    Trends Mol Med; 2012 Oct; 18(10):615-25. PubMed ID: 22917662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease.
    Gotfried J; Naftali T; Schey R
    Gastroenterology; 2020 Jul; 159(1):62-80. PubMed ID: 32333910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut feelings about the endocannabinoid system.
    Di Marzo V; Piscitelli F
    Neurogastroenterol Motil; 2011 May; 23(5):391-8. PubMed ID: 21481098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years.
    Maccarrone M; Di Marzo V; Gertsch J; Grether U; Howlett AC; Hua T; Makriyannis A; Piomelli D; Ueda N; van der Stelt M
    Pharmacol Rev; 2023 Sep; 75(5):885-958. PubMed ID: 37164640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the Endocannabinoid System as a Potential Anticancer Strategy.
    Ramer R; Schwarz R; Hinz B
    Front Pharmacol; 2019; 10():430. PubMed ID: 31143113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of cannabis based treatment in Crohn's disease.
    Naftali T
    Expert Rev Gastroenterol Hepatol; 2020 Apr; 14(4):253-257. PubMed ID: 32149543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.